Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta-Analysis

IF 8.9 1区医学

Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2024-11-11 DOI:10.1002/jcsm.13629

Yujie Zhang, Jingjing Zhang, Yunfan Zhan, Zhe Pan, Qiaohong Liu, Wei'an Yuan

引用次数: 0

Abstract

The relationship between sarcopenia and the prognosis of patients with tumours who received radio- and/or chemotherapy still needs to be determined. In this study, we aim to investigate the relationship between sarcopenia and adverse effects and mortality in patients with tumours that received radio- and/or chemotherapy, stratified by study design, tumour category, the method sarcopenia assessed, treatment options, study location and among other factors.

查看原文本刊更多论文

肌肉疏松症是肿瘤患者不良反应和死亡率的预后因素：系统回顾与元分析

肌肉疏松症与接受放射治疗和/或化疗的肿瘤患者预后之间的关系仍有待确定。本研究旨在根据研究设计、肿瘤类别、评估肌肉疏松症的方法、治疗方案、研究地点等因素，调查接受放射治疗和/或化疗的肿瘤患者的肌肉疏松症与不良反应和死亡率之间的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cachexia, Sarcopenia and Muscle Medicine-Orthopedics and Sports Medicine

自引率

12.40%

发文量

期刊介绍： The Journal of Cachexia, Sarcopenia, and Muscle is a prestigious, peer-reviewed international publication committed to disseminating research and clinical insights pertaining to cachexia, sarcopenia, body composition, and the physiological and pathophysiological alterations occurring throughout the lifespan and in various illnesses across the spectrum of life sciences. This journal serves as a valuable resource for physicians, biochemists, biologists, dieticians, pharmacologists, and students alike.